Brentuximab induces complete remission in 1/3 of patients w refractory Hodgkin's lymphoma. @hsplete reports. http://bit.ly/eDZb5w
10:03 AM - 6 Dec 2010
0 replies
2 retweets
0 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.